uniQure (QURE) Competitors $14.05 -0.16 (-1.13%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends QURE vs. BHC, CPRX, RXRX, GMTX, TWST, HCM, EWTX, KYMR, AMRX, and JANXShould you be buying uniQure stock or one of its competitors? The main competitors of uniQure include Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Recursion Pharmaceuticals (RXRX), Gemini Therapeutics (GMTX), Twist Bioscience (TWST), HUTCHMED (HCM), Edgewise Therapeutics (EWTX), Kymera Therapeutics (KYMR), Amneal Pharmaceuticals (AMRX), and Janux Therapeutics (JANX). These companies are all part of the "pharmaceutical products" industry. uniQure vs. Bausch Health Companies Catalyst Pharmaceuticals Recursion Pharmaceuticals Gemini Therapeutics Twist Bioscience HUTCHMED Edgewise Therapeutics Kymera Therapeutics Amneal Pharmaceuticals Janux Therapeutics Bausch Health Companies (NYSE:BHC) and uniQure (NASDAQ:QURE) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, community ranking, risk, analyst recommendations, institutional ownership, valuation and earnings. Is BHC or QURE more profitable? Bausch Health Companies has a net margin of -1.88% compared to uniQure's net margin of -837.80%. uniQure's return on equity of -188.82% beat Bausch Health Companies' return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Companies-1.88% -755.86% 5.11% uniQure -837.80%-188.82%-32.17% Does the MarketBeat Community favor BHC or QURE? uniQure received 294 more outperform votes than Bausch Health Companies when rated by MarketBeat users. Likewise, 70.67% of users gave uniQure an outperform vote while only 61.47% of users gave Bausch Health Companies an outperform vote. CompanyUnderperformOutperformBausch Health CompaniesOutperform Votes35961.47% Underperform Votes22538.53% uniQureOutperform Votes65370.67% Underperform Votes27129.33% Do institutionals and insiders believe in BHC or QURE? 78.7% of Bausch Health Companies shares are held by institutional investors. Comparatively, 78.8% of uniQure shares are held by institutional investors. 8.1% of Bausch Health Companies shares are held by insiders. Comparatively, 4.7% of uniQure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, BHC or QURE? Bausch Health Companies has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, uniQure has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Do analysts rate BHC or QURE? Bausch Health Companies presently has a consensus target price of $7.75, indicating a potential upside of 4.24%. uniQure has a consensus target price of $33.88, indicating a potential upside of 141.10%. Given uniQure's stronger consensus rating and higher probable upside, analysts clearly believe uniQure is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00uniQure 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, BHC or QURE? uniQure has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than uniQure, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health Companies$8.76B0.31-$592M-$0.48-15.49uniQure$28.59M23.96-$308.48M-$4.96-2.83 Does the media refer more to BHC or QURE? In the previous week, Bausch Health Companies had 6 more articles in the media than uniQure. MarketBeat recorded 6 mentions for Bausch Health Companies and 0 mentions for uniQure. uniQure's average media sentiment score of 0.50 beat Bausch Health Companies' score of 0.48 indicating that uniQure is being referred to more favorably in the news media. Company Overall Sentiment Bausch Health Companies Neutral uniQure Positive SummaryuniQure beats Bausch Health Companies on 12 of the 19 factors compared between the two stocks. Get uniQure News Delivered to You Automatically Sign up to receive the latest news and ratings for QURE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QURE vs. The Competition Export to ExcelMetricuniQurePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$684.84M$6.22B$5.21B$9.14BDividend YieldN/A2.94%5.13%4.02%P/E Ratio-2.839.8789.3417.36Price / Sales23.96309.211,240.0477.11Price / CashN/A61.4443.7535.97Price / Book3.246.055.314.79Net Income-$308.48M$154.90M$122.54M$225.00M7 Day Performance1.89%-0.32%0.59%2.62%1 Month Performance-17.26%0.43%2.55%3.81%1 Year Performance153.15%3.08%25.29%20.10% uniQure Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QUREuniQure3.7803 of 5 stars$14.05-1.1%$33.88+141.1%+153.2%$684.84M$28.59M-2.83500BHCBausch Health Companies3.3414 of 5 stars$7.49-4.9%$7.75+3.5%-8.7%$2.71B$9.47B-15.6020,270Short Interest ↓Positive NewsCPRXCatalyst Pharmaceuticals4.7324 of 5 stars$22.05+0.6%$32.86+49.0%+56.5%$2.63B$460.48M18.6980Short Interest ↑RXRXRecursion Pharmaceuticals2.4527 of 5 stars$6.71-2.5%$8.75+30.4%-32.2%$2.62B$64.60M-4.39400Gap DownGMTXGemini TherapeuticsN/A$59.25-5.3%N/A-6.2%$2.57BN/A-59.2530High Trading VolumeTWSTTwist Bioscience3.0531 of 5 stars$43.18-1.0%$51.90+20.2%+41.5%$2.56B$312.97M-11.99990Gap DownHCMHUTCHMED2.5866 of 5 stars$14.54-3.3%$19.00+30.7%-0.5%$2.53B$420.26M0.001,988Positive NewsGap DownEWTXEdgewise Therapeutics2.1412 of 5 stars$25.49+5.5%$43.17+69.3%+101.4%$2.41BN/A-16.9960Short Interest ↑Positive NewsGap DownKYMRKymera Therapeutics2.9252 of 5 stars$37.03-3.0%$55.38+49.5%+47.7%$2.40B$87.56M-15.82170AMRXAmneal Pharmaceuticals3.6935 of 5 stars$7.74-2.9%$10.00+29.2%+53.0%$2.40B$2.68B-11.387,700Short Interest ↓JANXJanux Therapeutics3.4757 of 5 stars$44.98-3.8%$89.90+99.9%+340.2%$2.36B$13.05M-38.4430Short Interest ↑ Related Companies and Tools Related Companies BHC Alternatives CPRX Alternatives RXRX Alternatives GMTX Alternatives TWST Alternatives HCM Alternatives EWTX Alternatives KYMR Alternatives AMRX Alternatives JANX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QURE) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding uniQure Please log in to your account or sign up in order to add this asset to your watchlist. Share uniQure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QURE Stock Alerts